Equatorial Guinea and the EU

European Commission authorises fourth safe and effective vaccine against COVID-19

Brussels, 11/03/2021 - 11:24, UNIQUE ID: 210312_25
Press releases

EU News 70/2021

Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the fourth COVID-19 vaccine authorised in the EU.

This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed by the Member States.

Editorial Sections: